Full Kit CJC 1295 w/o DAC 5mg

Full Kit of 10 vials of CJC 1295 w/o DAC 5mg per vial

CJC-1295 without DAC is a synthetic peptide that mimics the body’s natural growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to release growth hormone (GH) in a pulsatile manner, closely resembling the body’s natural secretion patterns. Unlike the DAC-modified version, it has a short half-life of approximately 30 minutes to 1 hour, requiring more frequent dosing to maintain effects.

Key Features & Benefits

• Pulsatile GH Release: Mimics natural GH secretion, supporting receptor sensitivity and reducing the risk of desensitization.

• Short Half-Life: Allows for quicker clearance from the body, potentially lowering the risk of prolonged side effects.

• Research Use: Used in scientific studies to investigate GH signaling, metabolic regulation, muscle growth, fat metabolism, recovery, and anti-aging effects.

• Common Stacking: Often combined with Ipamorelin, a GHRP peptide, to synergistically enhance GH and IGF-1 release through complementary receptor pathways. 

CJC-1295 sans DAC functions by emulating the physiological actions of endogenous growth hormone-releasing hormones (GHRH) within the organism. Upon administration, it binds to the growth hormone secretagogue receptor, inducing a synergistic elevation of growth hormone levels in a pulsatile manner. This orchestrated process governs the release of growth hormone pulses, furnishing a sustained augmentation in contrast to innate secretion patterns. By potentiating the organism’s responsiveness to GHRH and GHRP, CJC-1295 sans DAC intensifies the provocation of growth hormone synthesis, thereby fostering enhanced muscle hypertrophy, heightened vitality, and augmented lipid metabolism.

Owing to its abbreviated half-life, CJC1295 without DAC can be expeditiously metabolized within the organism, potentially mitigating the propensity for adverse reactions. Furthermore, the requisite for more frequent administrations facilitates facile titration of dosage and scheduling to cater to individual exigencies. The abbreviated half-life of CJC1295 sans DAC may also precipitate a swifter onset of action, particularly in exigencies necessitating rapid augmentation of growth hormone levels. In light of the divergent responses individuals may manifest towards protracted-release formulations such as DAC-incorporated CJC1295, CJC1295 without DAC proffers a pliable alternative, accommodating variances in physiological responsiveness.

Mechanism of Action

CJC-1295 without DAC works by mimicking the action of GHRH. When administered, it binds to GHRH receptors in the pituitary gland, which leads to an increase in the secretion of growth hormone. This increase in growth hormone can result in various physiological benefits, including muscle growth, fat loss, and improved recovery times.